Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 075693
Company: RITEDOSE CORP

Products on ANDA 075693

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	0.02%	SOLUTION;INHALATION	Prescription	AN	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 075693

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/26/2001	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/75693ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
05/20/2013	SUPPL-21	Labeling-Package Insert		Label is not available on this site.
10/21/2011	SUPPL-15	Labeling-Container/Carton Labels		Label is not available on this site.
12/17/2002	SUPPL-4	Manufacturing (CMC)-Facility		Label is not available on this site.
05/07/2002	SUPPL-3	Manufacturing (CMC)-Control		Label is not available on this site.
04/24/2002	SUPPL-2	Manufacturing (CMC)-Facility		Label is not available on this site.
10/11/2001	SUPPL-1	Labeling		Label is not available on this site.

Therapeutic Equivalents for ANDA 075693

IPRATROPIUM BROMIDE

SOLUTION;INHALATION; 0.02%
TE Code = AN

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	0.02%	SOLUTION;INHALATION	Prescription	No	AN	206543	LUOXIN AUROVITAS
IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	0.02%	SOLUTION;INHALATION	Prescription	No	AN	075562	NEPHRON
IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	0.02%	SOLUTION;INHALATION	Prescription	No	AN	075693	RITEDOSE CORP
IPRATROPIUM BROMIDE	IPRATROPIUM BROMIDE	0.02%	SOLUTION;INHALATION	Prescription	No	AN	207903	SUN PHARM